What Happened: Disclosed in a Form 4 filing on Thursday with the U.S. Securities and Exchange Commission, Carestio, President and CEO at Steris, executed a strategic derivative sale. This involved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results